Your browser doesn't support javascript.
loading
The Global Characterisation of a Drug-Dendrimer Conjugate - PEGylated poly-lysine Dendrimer.
Akhtar, Nadim; Ashford, Marianne B; Beer, Louisa; Bowes, Alex; Bristow, Tony; Broo, Anders; Buttar, David; Coombes, Steve; Cross, Rebecca; Eriksson, Emma; Guilbaud, Jean-Baptiste; Holman, Stephen W; Hughes, Leslie P; Jackman, Mark; Lawrence, M Jayne; Lee, Jessica; Li, Weimin; Linke, Rebecca; Mahmoudi, Najet; McCormick, Marc; MacMillan, Bryce; Newling, Ben; Ngeny, Maryann; Patterson, Claire; Poulton, Andy; Ray, Andrew; Sanderson, Natalie; Sonzini, Silvia; Tang, Yayan; Treacher, Kevin E; Whittaker, Dave; Wren, Stephen.
Afiliação
  • Akhtar N; New Modalities and Parenteral Development, Pharmaceutical Technology and Development, Operations, AstraZeneca, Macclesfield, UK.
  • Ashford MB; Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, UK.
  • Beer L; Chemical Development, Pharmaceutical Technology and Development, Operations, AstraZeneca, Macclesfield, UK.
  • Bowes A; Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, UK.
  • Bristow T; Chemical Development, Pharmaceutical Technology and Development, Operations, AstraZeneca, Macclesfield, UK. Electronic address: anthony.bristow@astrazeneca.com.
  • Broo A; Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
  • Buttar D; Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, UK.
  • Coombes S; Chemical Development, Pharmaceutical Technology and Development, Operations, AstraZeneca, Macclesfield, UK.
  • Cross R; Chemical Development, Pharmaceutical Technology and Development, Operations, AstraZeneca, Macclesfield, UK.
  • Eriksson E; Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
  • Guilbaud JB; Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, UK.
  • Holman SW; Chemical Development, Pharmaceutical Technology and Development, Operations, AstraZeneca, Macclesfield, UK.
  • Hughes LP; Oral Product Development, Pharmaceutical Technology and Development, Operations, AstraZeneca, Macclesfield, UK.
  • Jackman M; Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Lawrence MJ; Division of Pharmacy & Optometry, Stopford Building, University of Manchester, 99 Oxford Road, Manchester, M13 9PG, UK.
  • Lee J; Chemical Development, Pharmaceutical Technology and Development, Operations, AstraZeneca, Macclesfield, UK.
  • Li W; Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Linke R; Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, UK.
  • Mahmoudi N; ISIS Pulsed Neutron and Muon Source, Rutherford Appleton Laboratory, Chilton, Didcot, OX11 0QX, UK.
  • McCormick M; Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, UK.
  • MacMillan B; UNB MRI Centre, Department of Physics, PO Box 4400, Fredericton, NB E3B 5A3, Canada.
  • Newling B; UNB MRI Centre, Department of Physics, PO Box 4400, Fredericton, NB E3B 5A3, Canada.
  • Ngeny M; Oncology Regulatory Science & Strategy, AstraZeneca, Macclesfield, UK.
  • Patterson C; Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, UK.
  • Poulton A; Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, UK.
  • Ray A; New Modalities and Parenteral Development, Pharmaceutical Technology and Development, Operations, AstraZeneca, Macclesfield, UK.
  • Sanderson N; Chemical Development, Pharmaceutical Technology and Development, Operations, AstraZeneca, Macclesfield, UK.
  • Sonzini S; Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Tang Y; Regulatory Affairs, R&D, AstraZeneca, Shanghai, China.
  • Treacher KE; New Modalities and Parenteral Development, Pharmaceutical Technology and Development, Operations, AstraZeneca, Macclesfield, UK.
  • Whittaker D; Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, UK.
  • Wren S; New Modalities and Parenteral Development, Pharmaceutical Technology and Development, Operations, AstraZeneca, Macclesfield, UK.
J Pharm Sci ; 112(3): 844-858, 2023 03.
Article em En | MEDLINE | ID: mdl-36372229

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dendrímeros / Antineoplásicos Idioma: En Revista: J Pharm Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dendrímeros / Antineoplásicos Idioma: En Revista: J Pharm Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido